Carna Biosciences, Inc. engages in the drug discovery business. It operates through the Drug Discovery Support and Drug Discovery and Development segments. The Drug Discovery Support segment provides drug discovery supporting products and services such as kinase protein, profiling services, assay development, crystallography, and cell-based assay services. The Drug Discovery and Development segment develops new medicines for the treatment of cancer and inflammatory diseases using the kinase drug discovery platform called QuickScout. The company was founded on April 10, 2003 and is headquartered in Kobe, Japan.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
63
Frequently Asked Questions
What is Market Cap of Carna Biosciences Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Carna Biosciences Inc. market cap is $158.15M.
What is the 52-week high for Carna Biosciences Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Carna Biosciences Inc. 52 week high is $10.75 as of September 06, 2025.
What is the 52-week low for Carna Biosciences Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Carna Biosciences Inc. 52 week low is $10.75 as of September 06, 2025.
What is Carna Biosciences Inc. stock price today?
Carna Biosciences Inc. stock price today is $10.75.
What was Carna Biosciences Inc. stock price yesterday?
Carna Biosciences Inc. stock price yesterday was $11.75.
What is the PE ratio of Carna Biosciences Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Carna Biosciences Inc.’s P/E ratio is -1264.71.
What is the Price-to-Book ratio of Carna Biosciences Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Carna Biosciences Inc. P/B ratio is 5.3907.
What is the 50-day moving average of Carna Biosciences Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Carna Biosciences Inc. 50-day moving average is $10.75.
How many employess does Carna Biosciences Inc. has?
